Tokai Pharmaceuticals Appoints Khalid Mamlouk, Pharm.D. As Vice President, Head Of Medical Affairs

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven diseases, today announced the appointment of Khalid Mamlouk, Pharm.D. as vice president, head of medical affairs. Dr. Mamlouk joins the company from Algeta, bringing significant experience in oncology medical affairs, most recently with a focus in prostate cancer.

Help employers find you! Check out all the jobs and post your resume.